Internal Medicine, Rheumatology · Tucson, AZ
NPI
1073580924
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
403 W Cool Dr Ste 107
Tucson, AZ, 85704
Phone (520) 792-2199
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,809 services
Medicare patients, 2024
249
Average age 71
Drug cost, 2024
$9.3M
7,244 prescriptions
Company payments, 2025
$2,000
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ulker Tok was code 99215 (office e&m - established), 221 times for 169 patients. In total Ulker Tok billed 1,809 services in 23 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 221 | 169 | $129.41 | $29K |
| 99214 Office E&M - Established | Office | 98 | 88 | $84.91 | $8,321 |
| 99205 Office E&M - New | Office | 58 | 58 | $147.33 | $8,545 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 19 | 18 | $26.16 | $497 |
| 96401 Chemotherapy Administration | Office | 18 | 17 | $54.65 | $984 |
| 99204 Office E&M - New | Office | 16 | 16 | $110.39 | $1,766 |
By year: 2022 $115K for 3,818 services; 2023 $89K for 2,226 services; 2024 $60K for 1,809 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ulker Tok prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,321 prescriptions and refills. In total Ulker Tok wrote 7,244 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,321 | 2,078 | 471 | $19K |
| Hydroxychloroquine Sulfate Generic | 1,100 | 1,713 | 376 | $32K |
| Prednisone Generic | 888 | 1,182 | 366 | $3,652 |
| Folic Acid Generic | 412 | 763 | 171 | $2,269 |
| Humira(Cf) Pen Adalimumab | 376 | 381 | 87 | $3.4M |
| Leucovorin Calcium Generic | 242 | 417 | 85 | $5,778 |
| Gabapentin Generic | 217 | 315 | 77 | $3,966 |
| Enbrel Sureclick Etanercept | 195 | 197 | 46 | $1.5M |
| Alendronate Sodium Generic | 178 | 339 | 76 | $1,372 |
| Leflunomide Generic | 147 | 257 | 47 | $7,696 |
| Xeljanz Xr Tofacitinib Citrate | 127 | 127 | 38 | $780K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 106 | 106 | Under 11 | $829K |
| Meloxicam Generic | 84 | 127 | 29 | $334 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 84 | 144 | 37 | $1,191 |
| Rinvoq Upadacitinib | 82 | 82 | 21 | $549K |
Brand drugs: 1,461 claims; generic drugs: 5,706 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ulker Tok $2,000 ($2,000 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $608.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $608 |
| Pfizer Inc. PFE | 21 | $310 |
| Amgen Inc. AMGN | 20 | $307 |
| GlaxoSmithKline, LLC. GSK | 11 | $149 |
| Organon LLC OGN | 6 | $124 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $114 |
| Radius Health, Inc. | 4 | $73.35 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $49.94 |
| Genzyme Corporation SNY | 2 | $48.41 |
| Mallinckrodt Hospital Products Inc. | 1 | $33.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.